Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies

被引：93
|
作者：
Wong, Serre-Yu [1 ]
Dixon, Rebekah [1 ]
Pazos, Vicky Martinez [1 ]
Gnjatic, Sacha [2 ]
Colombel, Jean-Frederic [1 ]
Cadwell, Ken [3 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Med, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, Div Hematol Oncol, Precis Immunol Inst,Tisch Canc Inst, New York, NY 10029 USA
[3] NYU, Sch Med, Div Gastroenterol & Hepatol, Skirball Inst Biomol Med,Dept Microbiol,Dept Med, New York, NY USA
来源：
GASTROENTEROLOGY | 2021年 / 161卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1053/j.gastro.2021.04.025
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：715 / +
页数：8
相关论文
共 50 条
  • [1] Biologic therapies in inflammatory bowel disease
    Cohen, Lawrence B.
    Nanau, Radu M.
    Delzor, Faustine
    Neuman, Manuela G.
    [J]. TRANSLATIONAL RESEARCH, 2014, 163 (06) : 533 - 556
  • [2] Biologic therapies in inflammatory bowel disease
    Flamant, M.
    Bourreille, A.
    [J]. REVUE DE MEDECINE INTERNE, 2007, 28 (12): : 852 - 861
  • [3] SEROLOGIC PROFILE AND REACTIVATION OF HEPATITIS B IN RHEUMATIC AND INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH BIOLOGIC THERAPIES
    Romao, V. C.
    Teixeira, L.
    Vitor, S.
    Patita, M.
    Goncalves, M. J.
    Meireles, L.
    Saavedra, M. J.
    Correia, L.
    Canhao, H.
    da Silva, J. Canas
    da Silva, J. A. Pereira
    Fonseca, C.
    Marinho, R. T.
    Velosa, J.
    Santos, M. J.
    Fonseca, J. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 471 - 472
  • [4] Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
    Kappelman, Michael D.
    Weaver, Kimberly N.
    Boccieri, Margie
    Firestine, Ann
    Zhang, Xian
    Long, Millie D.
    [J]. GASTROENTEROLOGY, 2021, 161 (04) : 1340 - +
  • [5] Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
    Agha, Mounzer E.
    Blake, Maggie
    Chilleo, Charles
    Wells, Alan
    Haidar, Ghady
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
  • [6] Biologic therapies for chronic inflammatory bowel disease
    Martinez-Montiel, M. P.
    Munoz-Yagfie, M. T.
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2006, 98 (04) : 265 - 278
  • [7] Adherence to Biologic Therapies in Inflammatory Bowel Disease
    Wentworth, Brian
    Overby, M.
    Behm, Brian
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S49 - S49
  • [8] Nonadherence to Biologic Therapies in Inflammatory Bowel Disease
    Wentworth, Brian J.
    Buerlein, Ross C. D.
    Tuskey, Anne G.
    Overby, M. Ashley
    Smolkin, Mark E.
    Behm, Brian W.
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 2053 - 2061
  • [9] Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
    Pienkowski, Marek M.
    Pienkowski, Stefan M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (01) : 101 - 103
  • [10] Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
    Papa, Alfredo
    Lopetuso, Loris Riccardo
    Tursi, Antonio
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (01) : 205 - 206
12345